Genomic and high-throughput pharmacologic correlative analysis of 10 diffuse intrinsic pontine glioma
Elizabeth VanSickle, Abhinav Nagulapally, Delvano Capobianco, Jeff Bond, Rick Neubig, Tom Dexheimer, Giselle Sholler. Genomic and high-throughput pharmacologic correlative analysis of 10 diffuse intrinsic pontine glioma, 2nd Pediatric Precision Oncology Conference 2018, Scottsdale,[...]
Exceptional clinical response to molecular guided therapy in a patient with progressive lymphoepithelioma-like thymic carcinoma
M. Ghanim, Giselle Sholler, M. Hudspeth, L. Donahoo, W. Rieter, Geneveive Bergendahl, Gina Hanna, William Hendricks, Sara Byron, Abhinav Nagulapally, Jeff Bond, Jeff Trent, Jackie Kraveka. Exceptional clinical response to molecular[...]
Genomic analysis and precision therapy for high risk neuroblastoma at diagnosis and relapse
Jackie Kraveka, William Ferguson, Al Cornelius, Deanna Mitchell, William Roberts, Javier Oesterheld, Jeff Bond, Abhinav Nagulapally, William Hendricks, Sara Byron, Jeff Trent, Giselle Sholler. Genomic analysis and precision therapy for high[...]
Genomic analysis and precision therapy for recurrent and resistant osteosarcoma
William Ferguson, Al Cornelius, Jackie Kraveka, William Roberts, Javier Oesterheld, Abhinav Nagulapally, William Hendricks, Sara Byron, Jeff Trent, Giselle Sholler. Genomic analysis and precision therapy for recurrent and resistant osteosarcoma, 2nd Pediatric Precision[...]
Genomic analysis and precision therapy for recurrent and resistant ewing’s sarcoma
Al Cornelius, Jackie Kraveka, Bill Ferguson, Deanna Mitchell, William Roberts, Javier Oesterheld, Abhinav Nagulapally, William Hendricks, Sara Byron, Jeff Trent, Giselle Sholler. Genomic analysis and precision therapy for recurrent and resistant[...]
Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma
Cornelius A, Foley J, Bond J, Nagulapally AB, Steinbrecher J, Hendricks WP, Rich M, Yendrembam S, Bergendahl G, Trent JM, Sholler GS, Molecular Guided Therapy Provides Sustained Clinical Response in Refractory[...]
DFMO Maintains Remission in Relapsed/Refractory High Risk Neuroblastoma
Giselle Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey Bond, Kathleen Neville, Don Eslin, Valerie I. Brown, William Roberts, Randy Wada, Javier Oesterheld, Deanna Mitchell, Jessica Foley,Peter Zage, Jawhar Rawwas, Susan F.[...]
BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma
Zhao P, Hall J, Durston M, Voydanoff A, VanSickle E, Kelly S, Nagulapally, AB, Bond, J, Saulnier Sholler, G BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma. PLoS ONE June 29,[...]
Inhibition of Neuroblastoma Cell Growth by Difluoromethylornithine (DFMO) and Bortezomib through Suppression of LIN28 and MYCN
Rich M, Zhao P, Nagulapally A, Bond J, Saulnier Sholler G. Inhibition of Neuroblastoma Cell Growth by Difluoromethylornithine (DFMO) and Bortezomib through Suppression of LIN28 and MYCN, Journal of Cancer Therapy,[...]
DFMO synergizes with BET inhibitors targeting ODC and MYCN to impede neuroblastoma cell proliferation and tumor initiation
Sarah DeCou, Ping Zhao, Tracey Avequin, Abhinav Nagulapally, Jeffrey Bond, Giselle Saulnier Sholler. DFMO synergizes with BET inhibitors targeting ODC and MYCN to impede neuroblastoma cell proliferation and tumor initiation, American Association[...]